Aralez Pharmaceuticals Inc. (ARLZ): Mark A Glickman , Chief Commercial Officer of Aralez Pharmaceuticals Inc. purchased 25,000 shares on May 16, 2016. The Insider buying transaction was reported by the company on May 18, 2016 to the Securities and Exchange Commission. The shares were purchased at $3.68 per share for a total value of $92,050.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 18, 2016, James Patrick Tursi (Chief Medical Officer) purchased 4,500 shares at $3.79 per share price.On May 18, 2016, Eric Trachtenberg (GC, CCO & Secretary) purchased 10,000 shares at $3.76 per share price.Also, On May 17, 2016, Kenneth B Jr Lee (director) purchased 1,000 shares at $3.50 per share price.On May 16, 2016, Scott J Charles (CFO) purchased 50,000 shares at $3.49 per share price.
Company has been under the radar of several Street Analysts. is Reiterated by Chardan Capital Markets to Buy while Lowering the Price Target of the company shares to $ 10 from a previous price target of $15.50 . The Rating was issued on Mar 16, 2016.